Results 91 to 100 of about 3,260 (169)

Efficacy and safety of hetrombopag, a novel thrombopoietin receptor agonist, in children and adolescents with immune thrombocytopenia: results from a randomized, multicenter, placebo-controlled phase 3 trial. [PDF]

open access: yesJ Hematol Oncol
Wu R   +19 more
europepmc   +1 more source

The efficacy of immunosuppressive therapy with or without thrombopoietin receptor agonist in elderly patients with severe aplastic anemia. [PDF]

open access: yesAnn Hematol
Li J   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy